AIRNA, a transatlantic RNA editing biotech, is prepping to launch its lead asset into clinical trials with fuel from a $155 ...

Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.

Whey is the dairy industry's largest byproduct – but it also has enormous potential to reduce food waste and develop ...

Researchers have developed new AI models that can vastly improve accuracy and discovery within protein science. Potentially, the models will assist the medical sciences in overcoming present ...

Researchers have developed new AI models that can vastly improve accuracy and discovery within protein science. The models ...

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver de-targeting, in NHP study - - Preclinical muri ...

Siksha ‘O’ Anusandhan Deemed to be University (SOA) has signed a Memorandum of Understanding (MoU) with Insectika Biotech ...

Rapid Enrollment and Dosing of First Patients in PRECISE-AD Trial Underscores the Unmet Need for Better Treatment Options for Alzheimer’s ...

Researchers at Tecnológico de Monterrey have developed a breakthrough method to convert whey waste into single-cell protein ...

Vytrus Biotech unveils a revolutionary concept inspired by nature’s resilience to enhance skin longevity and radiance. Join ...

While Novartis and Bayer got there first, AstraZeneca, Bristol Myers Squibb and Eli Lilly are all vying to bring their ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...